Neurocognitive dysfunction in systemic lupus erythematosus: Association with antiphospholipid antibodies, disease activity and chronic damage

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Conti, Fabrizio ^a   Alessandri, Cristiano ^a   Perricone, Carlo ^a   Scrivo, Rossana ^a   Rezai, Soheila ^a   Ceccarelli, Fulvia ^a   Spinelli, Francesca Romana ^a   Ortona, Elena ^b   Marianetti, Massimo ^a   Mina, Concetta ^a   Valesini, Guido ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; DOUBLE STRANDED DNA ANTIBODY; ENDOTHELIAL CELL ANTIBODY; IMMUNOGLOBULIN M; NEDD8 ANTIBODY; NEDD8 PROTEIN; PHOSPHOLIPID ANTIBODY; UNCLASSIFIED DRUG; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN G; SEPT2 PROTEIN, HUMAN; SEPTIN;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BRAIN FUNCTION; COGNITION; COGNITIVE DEFECT; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; AGED; BLOOD; COHORT ANALYSIS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOLOGY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINUCLEAR; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; COGNITION DISORDERS; COHORT STUDIES; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; SEPTINS; YOUNG ADULT;

EID: 84858829777     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033824     Document Type: Article

References (56)

1. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature: The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes (1999) Arthritis Rheum 42: 599-608.
2. Buchbinder R, Hall S, Littlejohn GO, Ryan PF, (1988) Neuropsychiatric manifestations of systemic lupus erythematosus. Aust N Z J Med 18: 679-84.
3. Utset TO, Golden M, Siberry G, Kiri N, Crum RM, et al. (1994) Depressive symptoms in patients with systemic lupus erythematosus: association with central nervous system lupus and Sjogren's syndrome. J Rheumatol 21: 2039-45.
4. Carbotte RM, Denburg SD, Denburg JA, (1986) Prevalence of cognitive impairment in systemic lupus erythematosus. J Nerv Ment Dis 174: 357-64.
5. Hay EM, Black D, Huddy A, Creed F, Tomenson B, et al. (1992) Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 35: 411-6.
6. Kozora E, Thompson LL, West SG, Kotzin BL, (1996) Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 39: 2035-45.
7. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, et al. (2002) Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 58: 1214-20.
8. Johnson RT, Richardson EP, (1968) The neurological manifestations of systemic lupus erythematosus. Medicine 47: 337-369.
9. Kozora E, Hanly JG, Lapteva L, Filley CM, (2008) Cognitive dysfunction in systemic lupus erythematosus: past, present, and future. Arthritis Rheum 58: 3286-98.
10. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A, (2001) The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 57: 496-500.
11. Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Khamashta MA, et al. (2003) Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 30: 985-92.
12. Afeltra A, Garzia P, Mitterhofer AP, Vadacca M, Galluzzo S, et al. (2003) Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies. Neurology 61: 108-10.
13. Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K, (2004) Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 31: 2156-62.
14. Zhou HQ, Zhang FC, Tian XP, Leng XM, Lu JJ, et al. (2008) Clinical features and outcome of neuropsychiatric lupus in Chinese: analysis of 240 hospitalized patients. Lupus 17: 93-9.
15. Petri M, Naqibuddin M, Carson KA, Sampedro M, Wallace DJ, et al. (2008) Cognitive function in a systemic lupus erythematosus inception cohort. J Rheumatol 35: 1776-81.
16. Moorthy LN, Peterson MG, Hassett A, Baratelli M, Lehman TJ, (2010) Impact of lupus on school attendance and performance. Lupus 19: 620-7.
17. Ginsburg KS, Wright EA, Larson MG, Fossel AH, Albert M, et al. (1992) A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum 35: 776-82.
18. Carlomagno S, Migliaresi S, Ambrosone L, Sannino M, Sanges G, et al. (2000) Cognitive impairment in systemic lupus erythematosus: a follow-up study. J Neurol 247: 273-9.
19. Mikdashi J, Handwerger B, (2004) Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland Lupus Cohort. Rheumatology (Oxford) 43: 1555-60.
20. Greenwood DL, Gitlits VM, Alderuccio F, Sentry JW, Toh BH, (2002) Autoantibodies in Neuropsychiatric lupus. Autoimmunity 35: 79-86.
21. Denburg SD, Carbotte RM, Ginsberg JS, Denburg JA, (1997) The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. J Int Neuropsychol Soc 3: 377-86.
22. Hanly JG, Hong C, Smith S, Fisk JD, (1999) A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 42: 728-34.
23. Denburg JA, Carbotte RM, Denburg SD, (1987) Neuronal antibodies and cognitive function in systemic lupus erythematosus. Neurology 37: 464-7.
24. Conti F, Alessandri C, Bompane D, Bombardieri M, Spinelli FR, et al. (2004) Autoantibody profile in systemic lupus erythematosus with psychiatric manifestations: a role for antiendothelial-cell antibodies. Arthritis Res Ther 6: R366-R72.
25. Margutti P, Sorice M, Conti F, Delunardo F, Racaniello M, et al. (2005) Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations. Arthritis Res Ther 7: R896-903.
26. Lapteva L, Nowak M, Yarboro CH, Takada K, Roebuck-Spencer T, et al. (2006) Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 54: 2505-14.
27. Fragoso-Loyo H, Cabiedes J, Orozco-Narváez A, Dávila-Maldonado L, Atisha-Fregoso Y, et al. (2008) Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One 3: e3347.
28. Steup-Beekman G, Steens S, van Buchem M, Huizinga T, (2007) Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives. Lupus 16: 329-34.
29. Hanly JG, Robichaud J, Fisk JD, (2006) Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J Rheumatol 33: 1553-8.
30. Alarcón GS, Cianfrini L, Bradley LA, Sanchez ML, Brooks K, et al. (2002) Systemic lupus erythematosus in three ethnic groups: Measuring cognitive impairment with the cognitive symptoms inventory. Arthritis Rheum 47: 310-319.
31. Mikdashi JA, Esdaile JM, Alarcón GS, Crofford L, Fessler BJ, et al. Ad Hoc Committee on Lupus Response Criteria: Cognition Sub-committee (2007) Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials. Lupus 16: 418-25.
32. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25: 1271-7 Hochberg MC (1982) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40: 1725.
33. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, et al. (1992) Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35: 630-40.
34. Gladman DD, Ibanez D, Urowitz MB, (2002) Systemic Lupus Erythematosus Disease Activity Index 2000. J Rheumatol 29: 288-91.
35. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, et al. (1997) The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 40: 809-13.
36. van der Zee JM, Siegert CE, de Vreede TA, Daha MR, Breedveld FC, (1991) Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE). Clin Exp Immunol 84: 238-244.
37. Hahn RC, Petti DB, (1988) Minnesota multiphasic personality inventory-rated depression and the incidence of breast cancer. Cancer 61: 845.
38. Olazarán J, López-Longo J, Cruz I, Bittini A, Carreño L, (2009) Cognitive dysfunction in systemic lupus erythematosus: prevalence and correlates. Eur Neurol 62: 49-55.
39. Spinnler H, Tognoni G, (1987) Standardizzazione e taratura italiana di test neuropsicologici (Italian standardization of neuropsychological tests). Ital J Neurol Sci Suppl 8 pp. 25-62.
40. Carlesimo GA, Caltagirone C, Gainotti G, Nocentini U, (1995) Batteria per la valutazione del Deterioramento Mentale. II. Standardizzazione e affidabilità diagnostica nell'identificazione dei pazienti affetti da sindrome demenziale. Arch Psicol Neurol Psichiatr 56: 471-488.
41. Nichelli P, Leone M, Caronna A, et al. (2002) Taratura di un test di stime cognitive di impiego diagnostico in clinica: stime dei tempi e dei pesi (STEP). Nuova Rivista di Neurologia 12: 37-42.
42. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G, (1993) Wisconsin card sorting test. Manual, Psychological Assessment Resources, Odessa, FL. Psychological Assessment Resources.
43. Hanly JG, Fisk JD, McCurdy G, Fougere L, Douglas JA, (2005) Neuropsychiatric syndromes in patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol 32: 1459-6.
44. Hanly JG, Walsh NM, Fisk JD, Eastwood B, Hong C, et al. (1993) Cognitive impairment and autoantibodies in systemic lupus erythematosus. Br J Rheumatol 32: 291-6.
45. Schmidt R, Auer-Grumbach P, Fazekas F, Offenbacher H, Kapeller P, (1995) Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings. Stroke 26: 749-54.
46. Perricone R, Perricone C, De Carolis C, Shoenfeld Y, (2008) NK cells in autoimmunity: a two-edg'd weapon of the immune system. Autoimmun Rev 7: 384-90.
47. Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GR, (1984) Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 2: 47-51.
48. Asherson RA, Khamashta MA, Gil A, Vazquez JJ, Chan O, et al. (1989) Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med 86: 391-399.
49. Herranz MT, Rivier G, Khamashta MA, Blaser KU, Hughes GR, (1994) Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 37: 568-571.
50. Shoenfeld Y, Nahum A, Korczyn AD, Dano M, Rabinowitz R, et al. (2003) Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 12: 436-442.
51. Short S, Katzav A, Korczyn AD, Litvinijuk Y, Hersherson R, et al. (2002) Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus 11: 736-743.
52. Zandman-Goddard G, Chapman J, Shoenfeld Y, (2007) Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum 36: 297-315.
53. Abdel-Nasser AM, Ghaleb RM, Mahmoud JA, Khairy W, Mahmoud RM, (2008) Association of anti-ribosomal P protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus. Clin Rheumatol 27: 1377-85.
54. Valesini G, Alessandri C, Celestino D, Conti F, (2006) Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus. Ann N Y Acad Sci 1069: 118-28.
55. Utset TO, Fink J, Doninger NA, (2006) Prevalence of neurocognitive dysfunction and other clinical manifestations in disabled patients with systemic lupus erythematosus. J Rheumatol 33: 531-8.
56. Carbotte RM, Denburg SD, Denburg JA, (1995) Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J Rheumatol 22: 863-7.